Eagle Pharmaceuticals, Inc. Finite-Lived Intangible Assets, Gross
Eagle Pharmaceuticals, Inc. had Finite-Lived Intangible Assets, Gross of $134.78 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsGross · last filed 2023-08-09
- 2023-06-30: Finite-Lived Intangible Assets, Gross $134.78M.
- 2023-03-31: Finite-Lived Intangible Assets, Gross $134.78M.
- 2022-12-31: Finite-Lived Intangible Assets, Gross $134.78M.
- 2022-09-30: Finite-Lived Intangible Assets, Gross $119.75M.
| Period end | Finite-Lived Intangible Assets, Gross | Finite-Lived Intangible Assets, Gross as first filed |
|---|---|---|
| 2023-06-30 | $134.78M 10-Q/A · filed 2023-08-09 | |
| 2023-03-31 | $134.78M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $134.78M 10-Q/A · filed 2023-08-09 | |
| 2022-09-30 | $119.75M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $119.75M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $15.75M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $23.85M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $23.10M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $23.10M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $23.10M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $23.10M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $23.10M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $23.10M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $23.10M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $23.10M 10-K · filed 2021-03-05 | |
| 2019-09-30 | $23.10M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $23.10M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $23.10M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $34.32M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $34.32M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $34.32M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $34.32M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $34.32M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $34.32M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $34.32M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $34.32M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $34.32M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $25.22M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $11.22M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $34.32M 10-Q · filed 2017-05-08 | $11.22M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 |